Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells

  • R. Kalu|erovi| M
  • Moji| M
  • Gómez-Ruiz S
  • et al.
9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

© 2016 Bentham Science Publishers. In vitro antitumor activity of various organogallium(III) complexes (1–8) has been tested against CT26CL25, HCT116, SW480 colon cancer cell lines. CV and MTT assays were used to assess on the antiproliferative effect of investigated organogallium(III) complexes. From the investigated complexes, the most active was found to be tetranuclear compound 8 against CT26CL25 cells. Flow cytometric analysis of the CT26CL25 cells upon the treatment with 8 was performed in order to determine the role of apoptosis, caspase activation, autophagy and proliferation rate on the cell death caused with this compound. Results indicate cytotoxic potential of the tetranuclear complex 8 by inducing caspase independent apoptosis and blocking most of the cells before first division.

Cite

CITATION STYLE

APA

R. Kalu|erovi|, M., Moji|, M., Gómez-Ruiz, S., Mijatovi|, S., & Maksimovi|-Ivani|, D. (2015). Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry, 16(3), 359–364. https://doi.org/10.2174/1871520615666151007160319

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free